Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
3.970
-0.060 (-1.49%)
Nov 20, 2024, 4:00 PM EST - Market closed
Inovio Pharmaceuticals Revenue
Inovio Pharmaceuticals had revenue of $203.41K in the twelve months ending September 30, 2024, down -76.18% year-over-year. In the year 2023, Inovio Pharmaceuticals had annual revenue of $832.01K, down -91.89%.
Revenue (ttm)
$203.41K
Revenue Growth
-76.18%
P/S Ratio
n/a
Revenue / Employee
$1,667
Employees
122
Market Cap
103.62M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 832.01K | -9.43M | -91.89% |
Dec 31, 2022 | 10.26M | 8.49M | 478.23% |
Dec 31, 2021 | 1.77M | -5.64M | -76.05% |
Dec 31, 2020 | 7.41M | 3.30M | 80.24% |
Dec 31, 2019 | 4.11M | -26.37M | -86.51% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Quipt Home Medical | 244.23M |
Akoya Biosciences | 86.82M |
Century Therapeutics | 2.68M |
Adagene | 815.75K |
Fractyl Health | 97.00K |
INmune Bio | 42.00K |
INO News
- 5 days ago - European And US Vaccine Stocks Are Under Pressure - Here's WHy - Benzinga
- 6 days ago - Inovio Pharmaceuticals, Inc. (INO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 days ago - INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights - PRNewsWire
- 8 days ago - Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial - PRNewsWire
- 14 days ago - INOVIO to Present at Upcoming Scientific Conferences - PRNewsWire
- 15 days ago - INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024 - PRNewsWire
- 4 weeks ago - INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP - PRNewsWire
- 7 weeks ago - INOVIO Reports Inducement Grants Under Inducement Plan - PRNewsWire